Ana içeriğe atla

Kayıtlar

Nitelikli

How Corporate Health Care Leaders Maintain Their Impunity: The Case of Purdue Pharma's Funding of the Washington Legal Foundation to Attempt to Weaken the Responsible Corporate Officer Doctrine

The ongoing epidemic of narcotic (opioid) abuse, and the resulting rise in the deaths due to overdoses, has focused attention on pharmaceutical companies' aggressive promotion of these drugs which minimized their substantial risk. A recent article in the Intercept showed how the leadership of one such company tried to insulate itself from responsibility for such actions even while such promotions were continuing. Background: Impunity of Top Leaders of Big Health Care Organizations For years, we have railed against the impunity of top leaders of health care organizations.  We have noted that despite numerous legal settlements made by health care organizations of alllegations like fraud , bribery , and kickbacks , almost never do top leaders who presided over these actions face any negative consequences.  Lack of deterrence caused by such impunity appears to be a major cause of  the epidemic of continuing unethical behavior, crime and corruption on the part of large health car

Health Insurers "Expect at Least 20% Growth" From 2015 Enrollment

Health Care and Halloween 2014

Food Reward Friday

Is Meat Unhealthy? Part I

Figures Don't Lie But Liars Figure––Will There Be Some Obamacare Rate Shock in 2015?

Obesity → Diabetes

Obamacare is in Hiding Until After the Election

Food Reward Friday

The Most Transparent Administration Puts a Gag Order on HealthCare.gov Testing

Metabolic Effects of a Traditional Asian High-carbohydrate Diet

One Year Later: The Affordable Care Act's Launch on October 1, 2013––So How Did it Go?